EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 4.0

Enhancing early detection and treatment of psychosis in Germany: a protocol for the health economic evaluation of an artificial intelligence-guided complex intervention

Trutz Bommhardt, Jens Peschl, Frauke Schultze-Lutter, Nikolaos Koutsouleris, Eva Meisenzahl, Juliane Köberlein-Neu, CARE Study Group

BMJ Open · 2025

DOI: 10.1136/bmjopen-2025-103151 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift BMJ Open, 2025. Verfasst von Trutz Bommhardt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health Economics and Health Services Research, University of Wuppertal Schumpeter Faculty of Management and Economics - School of Business…. Hauptthemen laut MEDLINE: Artificial Intelligence, Psychotic Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gemeinsame Bundesausschuss.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction Psychosis, characterised by chronic symptoms often emerging in youth, imposes a substantial burden on individuals and healthcare systems. While early detection and intervention can mitigate this burden, there is limited evidence on the cost-effectiveness of such approaches. To address this lack of evidence, this study protocol outlines the health economic implications of an artificial intelligence (AI)-based intervention, the Computer-Assisted Risk-Evaluation (CARE), designed to prevent psychosis. The intervention uses AI technologies to enhance the diagnosis and treatment quality for individuals at high risk of psychosis. Methods and analysis The health economic evaluation has been designed alongside a 12-month multicentre randomised controlled trial comparing CARE with treatment as usual from both payer and societal perspectives. An implementation cost analysis will complement the evaluation, and long-term consequences beyond the trial will be explored descriptively. Based on a literature review, an initial economic logic model will guide subsequent analyses by depicting CARE’s programme theory. The cost-effectiveness assessment will include averted cases of manifest psychosis and quality-adjusted life-years using the EuroQol 5-Dimensions 3-Level instrument. Other effectiveness outcomes will also be incorporated into a cost–consequence analysis. Cost-effectiveness acceptability curves reflecting statistical uncertainty will be constructed, incorporating various payer and societal willingness-to-pay values. The implementation cost analysis will follow a mixed-methods approach to capture facility-specific costs. A dark logic model, emphasising negative outcomes, will be developed to investigate long-term consequences. Further, the initial economic logic model will be refined using trial data and expert interviews. This comprehensive approach aims to provide decision-makers not only with evidence on the cost-effectiveness of CARE, but also with a broader understanding of the implications of the intervention. Ethics and dissemination The study has received ethical approval and plans to disseminate its findings through publication in a peer-reviewed journal and conference presentations. Trial registration number NCT05813080 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligencePsychotic DisordersAdolescentHumansCost-Benefit AnalysisEarly DiagnosisGermanyQuality-Adjusted Life YearsRandomized Controlled Trials as TopicMulticenter Studies as Topic

Stichwörter der Autor:innen

HEALTH ECONOMICSPSYCHIATRYPrimary PreventionSchizophrenia & psychotic disorders

Autor:innen und Institutionen

  • Center for Health Economics and Health Services Research, University of Wuppertal Schumpeter Faculty of Management and Economics - School of Business and Economics, Wuppertal, Germany bommhardt@wiwi.uni-wuppertal.de.
  • Psychiatry and Psychotherapy, LVR-Klinikum Düsseldorf - Clinics of the Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Ludwig-Maximilians-Universitat Munich, Munich, Germany.
  • Center for Health Economics and Health Services Research, University of Wuppertal Schumpeter Faculty of Management and Economics - School of Business and Economics, Wuppertal, Germany.

Förderung

  • Gemeinsame Bundesausschuss

Zitieren

APA

Bommhardt, T., Peschl, J., Schultze-Lutter, F., Koutsouleris, N., Meisenzahl, E., Köberlein-Neu, J., & CARE Study Group (2025). Enhancing early detection and treatment of psychosis in Germany: a protocol for the health economic evaluation of an artificial intelligence-guided complex intervention. BMJ Open. https://doi.org/10.1136/bmjopen-2025-103151

Vancouver

Bommhardt T, Peschl J, Schultze-Lutter F, Koutsouleris N, Meisenzahl E, Köberlein-Neu J, et al. Enhancing early detection and treatment of psychosis in Germany: a protocol for the health economic evaluation of an artificial intelligence-guided complex intervention. BMJ Open. 2025. doi:10.1136/bmjopen-2025-103151

BibTeX
@article{Bommhardt2025,
  author = {Bommhardt, Trutz and Peschl, Jens and Schultze-Lutter, Frauke and Koutsouleris, Nikolaos and Meisenzahl, Eva and Köberlein-Neu, Juliane and CARE Study Group, CARE Study Group},
  title = {Enhancing early detection and treatment of psychosis in Germany: a protocol for the health economic evaluation of an artificial intelligence-guided complex intervention},
  journal = {BMJ Open},
  year = {2025},
  doi = {10.1136/bmjopen-2025-103151}
}
Kostenlos starten →